[A new approach to the treatment of sleep disorders in patients with cerebrovascular diseases].

[A new approach to the treatment of sleep disorders in patients with cerebrovascular diseases].

Likars'ka sprava (2003-05-31)

A E Rudenko, L V Korzhenevskiĭ, L M Bashkirova

ABSTRACT

A positive result has been obtained in treating sleep disorders in patients with chronic vascular affections of the brain with using the drugs donormyl and sonnate-KM [symbol: see text]. Donormyl is recommended for use in sleep disturbances (not very prolonged and not profound insomnia) in a 10-day therapeutic course as a first-choice drug.

MATERIALS

Product Number

Brand

Product Description

D-045

Supelco

Doxylamine succinate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant^®

D3775

Sigma-Aldrich

Doxylamine succinate salt